IRF4 and acute myeloid leukemia: Interestingly, 2 of the 4 AML patients over-expressing IRF4 fell into the very high ratio group (11.6< ratio) (Table 1) and were in fact positive for M5 maturation, whereas high expression was also observed in the M1 stage (without maturation).